{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:58:18Z","timestamp":1785895098388,"version":"3.56.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03: CA176743, R01: CA098803"],"award-info":[{"award-number":["R03: CA176743, R01: CA098803"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>To estimate the seroprevalence of <jats:italic>Chlamydia trachomatis<\/jats:italic> (CT), herpes simplex type-2 (HSV2), hepatitis C (HCV), Epstein-Barr virus (EBV) and nine human papilloma virus (HPV) types, and investigated factors associated with the seropositivity among men from three countries (Brazil, Mexico and U.S).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Archived serum specimens collected at enrollment for n = 600 men were tested for antibodies against CT, HSV2, HCV, EBV, and 9-valent HPV vaccine types (6\/11\/16\/18\/31\/33\/45\/52\/58) using multiplex serologic assays. Socio-demographic, lifestyle and sexual behavior data at enrollment were collected through a questionnaire.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Overall, 39.3% of the men were seropositive for CT, 25.4% for HSV2, 1.3% for HCV, 97.3% for EBV, 14.0% for at least one of the seven oncogenic HPV (types: 16\/18\/31\/33\/45\/52\/58), and 17.4% for HPV 6\/11. In the unadjusted models, age, race, smoking, sexual behavior variables, and seropositivity for high-risk HPV were significantly associated with the seropositivity for CT. In multivariable analyses, self-reported black race, higher numbers of lifetime female\/male sexual partners, current smoking, and seropositivity to high-risk HPV were significantly associated with increased odds of CT seropositivity. Odds of HSV2 seroprevalence were elevated among older men and those seropositive for high risk HPV.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Exposure to STIs is common among men. Prevention and screening programs should target high-risk groups to reduce the disease burden among men, and to interrupt the disease transmission to sexual partners.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0253005","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T17:29:56Z","timestamp":1624382996000},"page":"e0253005","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18\u201370 years from three countries"],"prefix":"10.1371","volume":"16","author":[{"given":"Shams","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Wathington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pawlita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa L.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lazcano-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Willhauck-Fleckenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5440-8859","authenticated-orcid":true,"given":"Anna R.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"1","key":"pone.0253005.ref001","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1745-7262.2008.00367.x","article-title":"Global epidemiology of sexually transmitted diseases","volume":"10","author":"CT Da Ros","year":"2008","journal-title":"Asian J Androl"},{"issue":"4","key":"pone.0253005.ref002","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/COH.0b013e32833a8844","article-title":"Contribution of sexually transmitted infections to the sexual transmission of HIV","volume":"5","author":"H Ward","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0253005.ref003","article-title":"Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection","author":"HJ Vriend","year":"2015","journal-title":"Cancer Med"},{"key":"pone.0253005.ref004","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0140-6736(98)90001-0","article-title":"Global epidemiology of sexually transmitted diseases","volume":"351","author":"AC Gerbase","year":"1998","journal-title":"The lancet"},{"issue":"14","key":"pone.0253005.ref005","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.vaccine.2013.07.087","article-title":"Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines","volume":"32","author":"SL Gottlieb","year":"2014","journal-title":"Vaccine"},{"issue":"suppl 8","key":"pone.0253005.ref006","doi-asserted-by":"crossref","first-page":"S759","DOI":"10.1093\/cid\/civ771","article-title":"Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines","volume":"61","author":"KA Workowski","year":"2015","journal-title":"Clinical Infectious Diseases"},{"key":"pone.0253005.ref007","volume-title":"Sexually Transmitted Diseases Holmes","author":"SP Holmes K","year":"2008","edition":"4"},{"issue":"12","key":"pone.0253005.ref008","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting","volume":"10","author":"L Newman","year":"2015","journal-title":"PLoS One"},{"key":"pone.0253005.ref009","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Diseases Surveillance 2013: Chlamydia. Available at: http:\/\/www.cdc.gov\/std\/stats13\/chlamydia.htm. Accessed July 26 2017."},{"issue":"3","key":"pone.0253005.ref010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.emcmed.2005.04.003","article-title":"Herp\u00e8s","volume":"2","author":"R Laurent","year":"2005","journal-title":"EMC\u2014M\u00e9decine"},{"issue":"1","key":"pone.0253005.ref011","doi-asserted-by":"crossref","first-page":"e114989","DOI":"10.1371\/journal.pone.0114989","article-title":"Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012","volume":"10","author":"KJ Looker","year":"2015","journal-title":"PloS one"},{"issue":"15","key":"pone.0253005.ref012","first-page":"456","article-title":"Seroprevalence of herpes simplex virus type 2 among persons aged 14\u201349 years\u2014United States, 2005\u20132008","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Morbidity and mortality weekly report"},{"key":"pone.0253005.ref013","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545313.054","volume-title":"The epidemiology of EBV and its association with malignant disease","author":"H Hjalgrim","year":"2007"},{"issue":"8","key":"pone.0253005.ref014","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","article-title":"Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6\u201319 years in the United States and factors affecting its acquisition","volume":"208","author":"HH Balfour","year":"2013","journal-title":"J Infect Dis"},{"issue":"3","key":"pone.0253005.ref015","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00268-017-4194-1","article-title":"Cohort Contributions to Race-and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA","volume":"42","author":"EW Beal","year":"2018","journal-title":"World journal of surgery"},{"issue":"7350","key":"pone.0253005.ref016","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/474S2a","article-title":"Introduction: a smouldering public-health crisis","volume":"474","author":"L. Gravitz","year":"2011","journal-title":"Nature"},{"issue":"4","key":"pone.0253005.ref017","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"K Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"pone.0253005.ref018","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"GL Armstrong","year":"2006","journal-title":"Annals of internal medicine"},{"issue":"12","key":"pone.0253005.ref019","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1099\/jgv.0.000620","article-title":"Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men study","volume":"97","author":"S Rahman","year":"2016","journal-title":"J Gen Virol"},{"issue":"11","key":"pone.0253005.ref020","doi-asserted-by":"crossref","first-page":"e0167173","DOI":"10.1371\/journal.pone.0167173","article-title":"Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study","volume":"11","author":"S Rahman","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"pone.0253005.ref021","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1158\/1055-9965.EPI-08-0151","article-title":"The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States","volume":"17","author":"AR Giuliano","year":"2008","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"9769","key":"pone.0253005.ref022","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study","volume":"377","author":"AR Giuliano","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"pone.0253005.ref023","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1373\/clinchem.2005.052381","article-title":"Multiplex human papillomavirus serology based on in situ\u2013purified glutathione S-transferase fusion proteins","volume":"51","author":"T Waterboer","year":"2005","journal-title":"Clinical chemistry"},{"issue":"12","key":"pone.0253005.ref024","doi-asserted-by":"crossref","first-page":"e0209379","DOI":"10.1371\/journal.pone.0209379","article-title":"Validation of Multiplex Serology detecting human herpesviruses 1\u20135","volume":"13","author":"N Brenner","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"pone.0253005.ref025","doi-asserted-by":"crossref","first-page":"e0152810","DOI":"10.1371\/journal.pone.0152810","article-title":"Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994\u20132012)","volume":"12","author":"SC Woodhall","year":"2017","journal-title":"PLoS One."},{"issue":"12","key":"pone.0253005.ref026","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1128\/CVI.00120-07","article-title":"Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics","volume":"14","author":"J Summerton","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"pone.0253005.ref027","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/infdis\/jit458","article-title":"Seroprevalence of herpes simplex virus types 1 and 2\u2014United States, 1999\u20132010","volume":"209","author":"H Bradley","year":"2014","journal-title":"J Infect Dis"},{"issue":"38","key":"pone.0253005.ref028","first-page":"834","article-title":"Prevalence of Chlamydia trachomatis genital infection among persons aged 14\u201339 years\u2014United States, 2007\u20132012","volume":"63","author":"Centers for Disease C, Prevention","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"pone.0253005.ref029","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12905-017-0428-5","article-title":"Frequency and genotypes of Chlamydia trachomatis in patients attending the obstetrics and gynecology clinics in Jalisco, Mexico and correlation with sociodemographic, behavioral, and biological factors","volume":"17","author":"N Casillas-Vega","year":"2017","journal-title":"BMC Womens Health"},{"issue":"5","key":"pone.0253005.ref030","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S0037-86822010000500005","article-title":"Neisseria gonorrhoeae and Chlamydia trachomatis infection in men attending STD clinics in Brazil","volume":"43","author":"MJ Barbosa","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"issue":"6","key":"pone.0253005.ref031","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/OLQ.0b013e318289c186","article-title":"Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study.","volume":"40","author":"CJ Alberts","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"38","key":"pone.0253005.ref032","first-page":"834","article-title":"Prevalence of chlamydia trachomatis genital infection among persons aged 14\u201339 years\u2013United States, 2007\u20132012","volume":"63","author":"Control CfD, Prevention","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9296","key":"pone.0253005.ref033","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(01)06886-6","article-title":"Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection","volume":"358","author":"KA Fenton","year":"2001","journal-title":"Lancet"},{"key":"pone.0253005.ref034","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1617-9625-4-12","article-title":"Tobacco use increases susceptibility to bacterial infection","volume":"4","author":"J Bagaitkar","year":"2008","journal-title":"Tob Induc Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0253005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T17:30:25Z","timestamp":1624383025000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0253005"}},"subtitle":[],"editor":[{"given":"Edward","family":"Gershburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0253005","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]}}}